Side effects that have been reported with Acomplia (rimonabant) according to an analysis by Arnie Astrup and others from the University of Copenhagen in Frederiksberg, Denmark include:
“Although the number of patients discontinuing therapy because of adverse events seemed to be small, high study attrition rates raise the possibility that some events were not documented,” Astrup noted.
© Copyright 2003-2012 - Larry Hobbs - All Rights Reserved.